Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 3/2005

01-06-2005

A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis

Authors: Wassim Y. Almawi, Hala Tamim, Raghid Kreidy, Georgina Timson, Elias Rahal, Malak Nabulsi, Ramzi R. Finan, Noha Irani-Hakime

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2005

Login to get access
Metadata
Title
A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis
Authors
Wassim Y. Almawi
Hala Tamim
Raghid Kreidy
Georgina Timson
Elias Rahal
Malak Nabulsi
Ramzi R. Finan
Noha Irani-Hakime
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2005
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-005-1313-x

Other articles of this Issue 3/2005

Journal of Thrombosis and Thrombolysis 3/2005 Go to the issue

OriginalPaper

Use of Recombinant Activated Factor VII in an Elderly Female Undergoing Acenocoumarol Thromboprophylaxis Requiring an Emergency Laparotomy

OriginalPaper

Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis

OriginalPaper

Patient-Specific Antithrombotic Strategies: Lessons Not Yet Learned from the Renal Insufficiency Paradigm

OriginalPaper

Mini-Dose Pump-Prime Aprotinin Inhibited Enhanced Fibrinolytic Activity and Reduced Blood Loss and Transfusion Requirements After Coronary Artery Bypass Surgery

OriginalPaper

An Examination of the Association Between Therapeutic Anticoagulation Control and Glycemic Control for Patients with Diabetes on Oral Anticoagulation Therapy

OriginalPaper

The Role of Gender and Other Factors as Predictors of Not Receiving Reperfusion Therapy and of Outcome in ST-Segment Elevation Myocardial Infarction
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits